David Bharucha insider trades
Open-market stock purchases and sales by David Bharucha, Chief Medical Officer at Milestone Pharmaceuticals Inc, from SEC Form 4 filings since Feb 15, 2022.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -74%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc | Bought (not open market) | — |
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc | Bought (not open market) | — |
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc | Bought (not open market) | — |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc | Sold | $23.6K |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 15, 2025 | MIST Milestone Pharmaceuticals Inc | Sold | $135K |
| Dec 12, 2025 | MIST Milestone Pharmaceuticals Inc | Bought (not open market) | — |
Companies traded
- MIST Milestone Pharmaceuticals Inc: 2 buys, 2 sales, last Feb 2, 2026